Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides s...
Life Beyond the Megacaps: The Complex Reality of 2026's Market Misfits
PacBio schedules conference call for second-quarter 2026 results
Inside the AI Hardware Boom: USD 250M Orders and Next-Gen Optical Links
PacBio director Christopher Smith resigns from board
Capital Divergence Signals Restructuring and AI Pivots Among Fringe US Equities
Stop Pitching AI and Gene Therapy. Which Biotechs Are Actually Delivering?